# Use of 68Ga-DOTATOC PET/CT-enterography for Detection of the Primary Lesion in Neuroendocrine Tumors of the Small Bowel

> **NCT06773624** · NA · RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 18 (estimated)

## Conditions studied

- Small Bowel Neoplasia
- Neuroendocrine (NE) Tumors

## Interventions

- **OTHER:** PET/CT-enterography with 68Ga-DOTATOC

## Key facts

- **NCT ID:** NCT06773624
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-23
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06773624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06773624, "Use of 68Ga-DOTATOC PET/CT-enterography for Detection of the Primary Lesion in Neuroendocrine Tumors of the Small Bowel". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06773624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*